Genetically elevated gamma-glutamyltransferase and Alzheimer's disease
Kunutsor, S. K., Laukkanen, J., & Burgess, S. (2018). Genetically elevated gamma-glutamyltransferase and Alzheimer's disease. Experimental Gerontology, 106, 61-66. https://doi.org/10.1016/j.exger.2018.03.001
Published inExperimental Gerontology
© 2018 The Authors. Published by Elsevier Inc. This is an open access article distributed under the terms of the Creative Commons License.
Observational epidemiological evidence supports a linear and independent association between serum gamma-glutamyltransferase (GGT) concentrations and the risk of Alzheimer's disease (AD). However, the causality of this association has not been previously investigated. We sought to assess the causal nature of this association using a Mendelian randomization (MR) approach. Using inverse-variance weighted MR analysis, we assessed the association between GGT and AD using summary statistics for single nucleotide polymorphism (SNP)-AD associations obtained from the International Genomics of Alzheimer's Project of 17,008 individuals with AD and 37,154 controls. We used 26 SNPs significantly associated with GGT in a previous genome-wide association study on liver enzymes as instruments. Sensitivity analyses to account for potential genetic pleiotropy included MR-Egger and weighted median MR. The odds ratio of AD was 1.09 (95% confidence interval, 0.98 to 1.22; p = 0.10) per one standard deviation genetically elevated GGT based on all 26 SNPs. The results were similar in both MR-Egger and weighted median MR methods. Overall, our findings cannot confirm a strong causal effect of GGT on AD risk. Further MR investigations using individual-level data are warranted to confirm or rule out causality. ...
ISSN Search the Publication Forum0531-5565
Publication in research information system
MetadataShow full item record
- Liikuntatieteiden tiedekunta 
Except where otherwise noted, this item's license is described as © 2018 The Authors. Published by Elsevier Inc. This is an open access article distributed under the terms of the Creative Commons License.
Showing items with similar title or keywords.
Reduced firing rates of pyramidal cells in the frontal cortex of APP/PS1 can be restored by acute treatment with levetiracetam Klee, Jan L.; Kiliaan, Amanda J.; Lipponen, Arto; Battaglia, Francesco P. (Elsevier, 2020)In recent years aberrant neural oscillations in various cortical areas have emerged as a common physiological hallmark across mouse models of amyloid pathology and patients with Alzheimer's disease. However, much less is ...
Physical activity as a protective factor for dementia and Alzheimer’s disease : systematic review, meta-analysis and quality assessment of cohort and case-control studies Iso-Markku, Paula; Kujala, Urho M; Knittle, Keegan; Polet, Juho; Vuoksimaa, Eero; Waller, Katja (BMJ Publishing Group, 2022)OBJECTIVE - Physical activity (PA) is associated with a decreased incidence of dementia, but much of the evidence comes from short follow-ups prone to reverse causation. This meta-analysis investigates the effect of study ...
Characterization of epileptic spiking associated with brain amyloidosis in APP/PS1 mice Gureviciene, Irina; Ishchenko, Irina; Ziyatdinova, Sofya; Jin, Nanxiang; Lipponen, Arto; Gurevicius, Kestutis; Tanila, Heikki (Frontiers Media, 2019)Epileptic activity without visible convulsions is common in Alzheimer’s disease (AD) and may contribute adversely to the disease progress and symptoms. Transgenic mice with amyloid plaque pathology also display epileptic ...
Physical activity may not be associated with long‐term risk of dementia and Alzheimer’s disease Kunutsor, Setor K.; Laukkanen, Jari A.; Kauhanen, Jussi; Willeit, Peter (Wiley, 2021)Background While it is well established that physical activity is associated with reduced risk of vascular and non‐vascular outcomes as well as mortality, evidence on the association between physical activity and dementia ...
Dysregulation of C-X-C motif ligand 10 during aging and association with cognitive performance Bradburn, Steven; McPhee, Jamie; Bagley, Liam; Carroll, Michael; Slevin, Mark; Al-Shanti, Nasser; Barnouin, Yoann; Hogrel, Jean-Yves; Pääsuke, Mati; Gapeyeva, Helena; Maier, Andrea; Sipilä, Sarianna; Narici, Marco; Robinson, Andrew; Mann, David; Payton, Antony; Pendleton, Neil; Butler-Browne, Gillian; Murgatroyd, Chris (Elsevier Inc., 2018)Chronic low-grade inflammation during aging (inflammaging) is associated with cognitive decline and neurodegeneration; however, the mechanisms underlying inflammaging are unclear. We studied a population (n = 361) of healthy ...